NEW YORK, June 23, 2016 /PRNewswire/ --
On Wednesday, June 22, 2016, the
NASDAQ Composite ended the trading session at 4,833.32, down 0.22%;
the Dow Jones Industrial Average edged 0.27% lower to finish at
17,780.83; and the S&P 500 closed at 2,085.45, down 0.17%.
Stock-Callers.com has initiated coverage on the following equities:
Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ:
AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), and Aduro BioTech
Inc. (NASDAQ: ADRO). Learn more about these stocks by accessing
their free trade alerts at:
http://stock-callers.com/registration
Dublin, Ireland headquartered
biopharmaceutical Company, Alkermes PLC's stock advanced 2.84% to
close the day at $43.04 with a total
volume of 795,144 shares traded. The Company's shares have gained
0.37% in the last one month and 39.02% in the previous three
months. The stock is trading 3.44% above its 50-day moving average.
Additionally, Alkermes' stock has a Relative Strength Index (RSI)
of 49.90. Sign up and read the free notes on ALKS at:
http://stock-callers.com/registration/?symbol=ALKS
Waltham, Massachusetts
headquartered specialty pharmaceutical Company, AMAG
Pharmaceuticals Inc.'s stock finished Wednesday's session 3.51%
higher at $24.46 with a total volume
of 1.01 million shares traded. Over the last one month and the
previous three months, the Company's shares have surged 29.83% and
18.28%, respectively. The stock is trading above its 50-day moving
average by 8.26%. AMAG Pharmaceuticals' stock has an RSI of 60.77.
The complimentary notes on AMAG can be downloaded in PDF format
at:
http://stock-callers.com/registration/?symbol=AMAG
On Wednesday, shares in IDEXX Laboratories Inc. ended the
session 0.42% higher at $90.04 with a
total volume of 412,217 shares traded. Shares of the Company traded
at a PE ratio of 43.43. The Company's shares have gained 2.18% in
the last one month, 19.32% in the previous three months, and 36.90%
in the past one year. The stock is trading 4.51% above its 50-day
moving average and 18.62% above its 200-day moving average.
Moreover, shares of IDEXX Laboratories which together with its
subsidiaries, develops, manufactures, and distributes products and
services primarily for the companion animal veterinary, livestock
and poultry, water testing, and dairy markets worldwide, have an
RSI of 60.30. Register for free on Stock-Callers.com and access the
latest research on IDXX at:
http://stock-callers.com/registration/?symbol=IDXX
On Wednesday, shares in Berkeley,
California-based clinical-stage immunotherapy Company, Aduro
BioTech Inc., recorded a trading volume of 572,092 shares, which
was higher than their three months average volume of 528,810
shares. The stock ended the day 7.00% lower at $10.23. The stock is trading below its 50-day
moving average by 15.58%. Furthermore, shares of Aduro BioTech have
an RSI of 33.07. Get free access to your trade alert on ADRO
at:
http://stock-callers.com/registration/?symbol=ADRO
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored
reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and
micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
SC has not been compensated; directly or indirectly; for
producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer") represented by a
credentialed financial analyst [for further information on analyst
credentials, please email info@stock-callers.com . Rohit Tuli, a CFA® charterholder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author
according to the procedures outlined by SC. SC is not entitled to
veto or interfere in the application of such procedures by the
third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content
outside of this document has no association with the Author or the
Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any
error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is
accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the
Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither SC nor any party affiliated with us is a
registered investment adviser or broker-dealer with any agency or
in any jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly.
If you're a company we are
covering and wish to no longer feature on our coverage list contact
us via email and/or phone between 09:30 EDT
to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street,
Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Chelmsford Park SA